Initial Aspirin Dose and Outcome Among ST-Elevation Myocardial Infarction Patients Treated With Fibrinolytic Therapy | Zendy

Jeffrey S. Berger | Zendy; Amanda Stebbins | Zendy; Christopher B. Granger | Zendy; E. Magnus Ohman | Zendy; Paul W. Armstrong | Zendy; Frans Van de Werf | Zendy; Harvey D. White | Zendy; R. John Simes | Zendy; Robert A. Harrington | Zendy; Robert M. Califf | Zendy; Eric D. Peterson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Initial Aspirin Dose and Outcome Among ST-Elevation Myocardial Infarction Patients Treated With Fibrinolytic Therapy

Author(s) -

Jeffrey S. Berger,

Amanda Stebbins,

Christopher B. Granger,

E. Magnus Ohman,

Paul W. Armstrong,

Frans Van de Werf,

Harvey D. White,

R. John Simes,

Robert A. Harrington,

Robert M. Califf,

Eric D. Peterson

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.729558

Subject(s) - medicine , aspirin , fibrinolytic therapy , myocardial infarction , cardiology , fibrinolytic agent , fibrinolysis , antithrombotic

Although treatment with immediate aspirin reduces morbidity and mortality in ST-elevation myocardial infarction, the optimal dose is unclear. We therefore compared the acute mortality and bleeding risks associated with the initial use of 162 versus 325 mg aspirin in fibrinolytic-treated ST-elevation myocardial infarction patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research